Does Bausch Health Have Enough Cash For A Covid-19 Led Recession?
- Wednesday, June 24, 2020, 7:16
- Market
- Add a comment
Bausch Health Companies’ stock, formerly called Valeant Pharmaceuticals, and best known for its contact lenses and branded generic drugs, has declined by more than 35% this year, due to the impact of Covid-19 on its business.A Covid recession will impact the company’s revenues and cash flows…
About the Author
admin123 has written 23442 stories on this site.
